Anavex Life Sciences Corp (AVXL)

[sumbuysumsell]

If we can believe for a second that the EMA MAA process involves LoQ items and conversations about how Anavex would be able to fund launching Blarcamesine in the EMA then for me dilution at this stage is a very good thing. Even the recent ATM agreements.
ChatGPT says the initial costs to launch a new CNS medication in the EMA is ~$150M.
Imagine getting asked something along the lines of: 'If we approve this drug how will you pay for bringing it to market?'
The potential for the EMA to ask Anavex to build up a war chest is a very good problem to have.